Avricore Health (AVCRF) Cash from Operations Growth (1y) (2015 - 2025)
Avricore Health (AVCRF) Cash from Operations Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -101.15% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 64.87% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.77% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 11.89% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -9.63% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 25.34% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 8.80% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 20.42% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -28.11% |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -174.35% |
| Jun 30, 2025 | -144.55% |
| Mar 31, 2025 | -49.25% |
| Sep 30, 2024 | 250.28% |
| Jun 30, 2024 | 203.26% |
| Mar 31, 2024 | 339.24% |
| Dec 31, 2023 | 1,118.76% |
| Sep 30, 2023 | 805.89% |
| Jun 30, 2023 | 153.78% |
| Mar 31, 2023 | 144.57% |
| Dec 31, 2022 | 91.78% |
| Sep 30, 2022 | 105.90% |
| Jun 30, 2022 | 33.19% |
| Mar 31, 2022 | 33.18% |
| Dec 31, 2021 | 19.61% |
| Sep 30, 2021 | -90.45% |
| Jun 30, 2021 | -49.85% |
| Mar 31, 2021 | 28.42% |
| Dec 31, 2020 | -532.14% |
| Sep 30, 2020 | 44.63% |